PD‐L1 interacts with the corresponding receptor PD‐1 (Programmed cell death protein 1) expressed on the surface of activated T cells and B lymphocytes, which delivers inhibitory signals to mediate the immune escape of tumour cells and resistance to conventional chemoradiotherapy.16 This evidence concerns the gene PDCD1 and neoplasm.